UNCOVER - a Non-interventional Study to Investigate Undiagnosed Severe Asthma

Karl Landsteiner Institute for Clinical and Experimental Pneumology174 enrolled

Overview

UNCOVER is a non-interventional study to investigate the prevalence of difficult-to-treat and severe Asthma eligible for treatment with biologics in a cohort of patients with suspected, so far undiagnosed severe Asthma which were previously treated by General practitioners and Office-based pulmonologists.

Study Type

OBSERVATIONAL

Enrollment

174

Conditions

Asthma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years of age or older at inclusion * written informed consent * currently diagnosed with Asthma fulfilling at least one of the criteria of potential severe Asthma * willing and able to complete the study questionnaire miniAQLQ Exclusion Criteria: * biological Treatment for Asthma during the past 12 months * participation in a clinical Trial within the last 3 months * patients who are not able to read or write, who do not understand the nature of the study or the ICF or who are dependent from the investigator

Locations (1)

Karl Landsteiner Institute for Clinical and Experimental Pneumology, Klinik Hietzing

Vienna, Austria

Outcomes

Primary Outcomes

The Primary objective is the Investigation of the prevalence of difficult-to-treat and severe Asthma eligible for Treatment with biologics.

Number of patients with diagnosis of severe Asthma according to the ATS/ERS Definition of severe Asthma and number of severe Asthma patients eligible for one or more biologic Treatments for Asthma.

Time frame: 18 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.